FMR LLC

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 315066 BOSTON, MA

Position in IKT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$210,565

+$89,668 QoQ

Shares Held

103,727

+44.1% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 105 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,424,667,384 across 370 Biotechnology names. IKT ranks #242 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	5,231,452	$4,853,584,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	15,023,962	$4,522,663,276
3	MRNA	Moderna, Inc.	51,859,891	$3,631,748,165
4	ROIV	Roivant Sciences Ltd.	81,020,390	$2,867,311,601
5	RVMD	Revolution Medicines, Inc.	12,200,422	$2,284,895,029
6	IONS	Ionis Pharmaceuticals Inc	24,631,956	$1,953,067,789
7	INSM	INSMED Inc	16,143,583	$1,721,228,815
8	KRYS	Krystal Biotech, Inc.	4,418,197	$1,642,111,277

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$210,565	103,727	+44.1%	Shares	Defined	2026-08-13
2026-03-31	$120,897	71,963	+25.4%	Shares	Defined	2026-05-15
2025-12-31	$117,616	57,374	-45.8%	Shares	Defined	2026-02-17
2025-09-30	$171,347	105,770	-26.7%	Shares	Defined	2025-11-13
2025-06-30	$281,266	144,239	-66.7%	Shares	Defined	2025-08-14
2022-09-30	$394,303	433,300	0.0%	Shares	Defined	2022-11-10
2022-06-30	$321,941	433,300	0.0%	Shares	Defined	2022-08-12
2022-03-31	$641,284	433,300	0.0%	Shares	Defined	2022-05-13
2021-12-31	$636,951	433,300	0.0%	Shares	Defined	2022-02-14
2021-09-30	$823,270	433,300	0.0%	Shares	Defined	2022-02-14
2021-06-30	$1,213,240	433,300	+333.3%	Shares	Defined	2021-08-13
2021-03-31	$601,000	100,000	0.0%	Shares	Defined	2021-05-14
2020-12-31	$690,000	100,000	—	Shares	Defined	2021-02-08
No filing history on record for this holder in this stock.